1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > PharmaPoint: Crohn’s Disease - Current and Future Players

PharmaPoint: Crohn’s Disease - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Crohn’s Disease - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Crohn’s Disease Market. The report identifies and analyses the key companies shaping and driving the global Crohn’s Disease market. The report provides insight into the competitive Crohn’s Disease landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Crohn’s Disease
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Crohn’s Disease sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Crohn’s Disease market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Crohn’s Disease market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Crohn’s Disease - Current and Future Players
1 Table of Contents

2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
2.3 Upcoming Related Reports 12
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Drivers and Barriers - Global Issues 17
4 Current and Future Players 22
4.1 Overview 22
4.2 Trends in Corporate Strategy 24
4.3 Company Profiles 26
4.3.1 Johnson and Johnson 26
4.3.2 AbbVie 28
4.3.3 UCB 30
4.3.4 Biogen Idec 31
4.3.5 Takeda 33
4.3.6 ChemoCentryx 35
5 Appendix 37
5.1 Bibliography 37
5.2 Abbreviations 38
5.3 Methodology 40
5.4 Forecasting Methodology 40
5.4.1 Diagnosed CD Patients 40
5.4.2 Percent Drug-Treated Patients 41
5.4.3 General Pricing Assumptions 41
5.4.4 Generic Erosion 42
5.4.5 Physicians and Specialists Included in This Study 43
5.5 Primary Research - Prescriber Survey 45
5.6 About the Authors 46
5.6.1 Author/Reviewer 46
5.6.2 Global Head of Healthcare 46
5.7 About GlobalData 47
5.8 Disclaimer 47

1.1 List of Tables

Table 1: Global Sales Forecasts ($) for CD, 2012-2022 15
Table 2: Global CD Market - Drivers and Barriers, 2012-2022 17
Table 3: Key Companies in the CD Market, 2013 23
Table 4: JandJ's CD Portfolio Assessment, 2013 27
Table 5: JandJ's CD SWOT Analysis, 2013 27
Table 6: AbbVie's CD Portfolio Assessment, 2013 29
Table 7: Abbott/AbbVie's CD SWOT Analysis, 2013 29
Table 8: UCB's CD Portfolio Assessment, 2013 30
Table 9: UCB's CD SWOT Analysis, 2013 31
Table 10: Biogen Idec's CD Portfolio Assessment, 2013 32
Table 11: Biogen Idec's CD SWOT Analysis, 2013 33
Table 12: Takeda's CD Portfolio Assessment, 2013 34
Table 13: Takeda's CD SWOT Analysis, 2013 34
Table 14: ChemoCentryx's CD Portfolio Assessment, 2013 35
Table 15: ChemoCentryx's CD SWOT Analysis, 2013 36
Table 16: Physicians Surveyed, By Country 45

1.2 List of Figures

Figure 1: Global Sales for CD by Region, 2012-2022 16
Figure 2: Company Portfolio Gap Analysis in CD, 2012-2022 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

Pathology Statistics in Iran - Forecast

  • December 2016
    8 pages
  • Pathology  

  • Iran  

View report >

Public Health Markets in the UK

  • December 2016
    45 pages
  • Public Health  

    Obesity  

    Food  

  • United Kingdom  

    Europe  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.